LocalBusiness.com reported that Raleigh's INC Research has closed a third round of funding worth $3 million from undisclosed investors. Company officials said the financing round will be used to help open new offices in the United States, Canada and Europe. INC Research provides drug development services in the areas of neurology, psychiatry and pain management. The company also offers specialized, clinical data services for all types of therapeutic areas.
CED News
« Adhesion Technologies Nets $15 Million | Main | Level 8 Acquires StarQuest Software »